HIGHLIGHTS
SUMMARY
Valvular heart disease (VHD) is among the major contributors to the substantial loss of quality of life, functional capacity, and longevity of life around the globe with significantly varying epidemiology in relation to the economic plight of the region. Among various other factors, the presence of concomitant obstructive coronary artery disease (CAD) in patients with rheumatic VHD is found to be associated with an increased risk of adverse clinical outcomes and complications.3-7 CAD is more common among patients with degenerative or calcific valvular lesions due to shared pathophysiological risk factors such as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.